
Andreessen Horowitz
+346.3%
13F reported fund value
$14,214,935,834
Holdings
Activity
DisclosedValueChange
- $14,214,935,834+$12,924,323,36613F for Q2 2026+2 more
New positions
MoveSinceTraded- +$12.8bn+22%n/aSPCX24/7SpaceX
- +$14.9m+21%n/aRBLX<![Cdata[Roblox Corp]]>
- +$3.08mn/an/aKLRA<![Cdata[Kailera Therapeutics Inc]]>
Decreased
MoveSinceTraded- −$181m-14%n/aFIG24/5Figma
- −$16.1m+120%n/aNAUT<![Cdata[Nautilus Biotechnology Inc]]>
14 positions unchanged
The filing on EDGAR - $1,290,612,468−$289,172,11013F for Q1 2026+1 more
New positions
MoveSinceTraded- +$32.0mn/an/aNo ticker<![Cdata[Damora Therapeutics Inc]]>
- +$7.42m-5%n/aAKTS<![Cdata[Aktis Oncology Inc]]>
- +$5.48m-7%n/aBTGO24/5BitGo Holdings
Decreased
MoveSinceTraded- −$14.5m+23%n/aOMDA<![Cdata[Omada Health Inc]]>
12 positions unchanged
The filing on EDGAR - $1,579,784,578+$184,893,68813F for Q4 2025
New positions
MoveSinceTraded- +$464m+115%n/aNAVN<![Cdata[Navan Inc]]>
Decreased
MoveSinceTraded- −$146m+105%n/aRVMD<![Cdata[Revolution Medicines Inc]]>
- −$18.2m+78%n/aOMDA<![Cdata[Omada Health Inc]]>
10 positions unchanged
The filing on EDGAR - $1,394,890,890+$1,081,981,63613F for Q3 2025
New positions
MoveSinceTradedClosed positions
MoveSinceTraded- −$3.31m-71%n/aOPEN24/5Opendoor Technologies
9 positions unchanged
The filing on EDGAR - $312,909,254−$387,963,25913F for Q2 2025+2 more
New positions
MoveSinceTraded- +$84.4m0%n/aOMDA<![Cdata[Omada Health Inc]]>
Closed positions
MoveSinceTraded- −$292m-22%n/aDASH24/5DoorDash
- −$153m+32%n/aIOTSamsara
- −$37.7mn/an/aACCD<![Cdata[Accolade Inc]]>
- −$261kn/an/aCYNCyngn
9 positions unchanged
The filing on EDGAR - $700,872,513−$44,383,13313F for Q1 2025
New positions
MoveSinceTraded- +$18.7m+186%n/aMAZE<![Cdata[Maze Therapeutics Inc]]>
- +$261kn/an/aCYNCyngn
11 positions unchanged
The filing on EDGAR - $745,255,646−$392,534,82413F for Q4 2024+1 more
New positions
MoveSinceTraded- +$11.1m-11%n/aCAMP<![Cdata[Camp4 Therapeutics Corp]]>
Closed positions
MoveSinceTraded- −$444m+96%n/aHOOD24/5Robinhood Markets
- −$114m-10%n/aCARTMaplebear
Increased
MoveSinceTraded- +$1.27m+50%n/aBIOA<![Cdata[Bioage Labs Inc]]>
10 positions unchanged
The filing on EDGAR - $1,137,790,470−$34,502,17713F for Q3 2024+3 more
New positions
MoveSinceTraded- +$62.7m-67%n/aBIOA<![Cdata[Bioage Labs Inc]]>
- +$885kn/an/aDNA<![Cdata[Ginkgo Bioworks Holdings Inc]]>
- +$224kn/an/aNo tickerCyngn
Closed positions
MoveSinceTraded- −$1.45mn/an/aNo tickerGinkgo Bioworks
- −$423kn/an/aSHPWQShapeways
- −$420kn/an/aCYNCyngn
10 positions unchanged
The filing on EDGAR - $1,172,292,647−$210,134,02713F for Q2 2024
- $1,382,426,674n/a13F for Q1 2024+4 more
New positions
MoveSinceTraded- +$5.04mn/an/aNo tickerGinkgo Bioworks
Closed positions
MoveSinceTraded- −$394m-19%n/aCOIN24/7Coinbase Global
- −$16.6m0%n/aSPLKSplunk
- −$1.36m-88%n/aNVTAInvitae
- −$1.15mn/an/aNo tickerLiveperson
Increased
MoveSinceTraded- +$57.1m+425%n/aRVMD<![Cdata[Revolution Medicines Inc]]>
Decreased
MoveSinceTraded- −$133m+38%n/aCARTMaplebear
10 positions unchanged
The filing on EDGAR
Coverage
92%
$13.1bn of $14.2bn
- Tokenised stocks
- 92%
- Held as USDT
- 8%
No token yet138%
- 5%NAVN<![CDATA[NAVAN INC]]>
- 1%RVMD<![CDATA[REVOLUTION MEDICINES INC]]>
- 0.6%BIOA<![CDATA[BIOAGE LABS INC]]>
- 0.4%ERAS<![CDATA[ERASCA INC]]>
- 0.4%MAZE<![CDATA[MAZE THERAPEUTICS INC]]>
- 0.2%OMDA<![CDATA[OMADA HEALTH INC]]>
- 0.1%NAUT<![CDATA[NAUTILUS BIOTECHNOLOGY INC]]>
- 0.1%RBLX<![CDATA[ROBLOX CORP]]>
- 0.1%AKTS<![CDATA[AKTIS ONCOLOGY INC]]>
- 0.1%CAMP<![CDATA[CAMP4 THERAPEUTICS CORP]]>
- 0.0%KLRA<![CDATA[KAILERA THERAPEUTICS INC]]>
- 0.0%DNA<![CDATA[GINKGO BIOWORKS HOLDINGS INC]]>
- 0.0%IPST<![CDATA[IP STRATEGY HOLDINGS INC]]>
Other instruments10.2%
- 0.2%No ticker<![CDATA[DAMORA THERAPEUTICS INC]]>